Curis Inc financial data

Symbol
CRIS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
128 Spring Street, Building C, Suite 500, Lexington, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 187 % -64.4%
Debt-to-equity -3.39K % -1723%
Return On Equity 2.91K %
Return On Assets -88.5 % -61.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.49M shares +44%
Common Stock, Shares, Outstanding 8.49M shares +44%
Entity Public Float 40.6M USD -50.7%
Common Stock, Value, Issued 85K USD +44.1%
Weighted Average Number of Shares Outstanding, Basic 6.31M shares +19.1%
Weighted Average Number of Shares Outstanding, Diluted 6.31M shares +19.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 10.9M USD +8.83%
General and Administrative Expense 16.8M USD -9.96%
Costs and Expenses 55.5M USD -4.98%
Operating Income (Loss) -44.5M USD +7.84%
Nonoperating Income (Expense) 1.15M USD +25.5%
Net Income (Loss) Attributable to Parent -43.4M USD +8.49%
Earnings Per Share, Basic -6.88 USD/shares +23.2%
Earnings Per Share, Diluted -6.88 USD/shares +23.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20M USD -25.1%
Marketable Securities, Current 0 USD -100%
Cash, Cash Equivalents, and Short-term Investments 20M USD -64.5%
Accounts Receivable, after Allowance for Credit Loss, Current 3.35M USD +19.9%
Assets, Current 26.4M USD -56.7%
Property, Plant and Equipment, Net 231K USD -46.8%
Operating Lease, Right-of-Use Asset 3.16M USD +3.5%
Goodwill 8.98M USD 0%
Other Assets, Noncurrent 3.36K USD
Assets 41.3M USD -46.6%
Accounts Payable, Current 3.02M USD -4.67%
Employee-related Liabilities, Current 3.26M USD -12.1%
Accrued Liabilities, Current 7.11M USD -21.3%
Liabilities, Current 19M USD -13.6%
Operating Lease, Liability, Noncurrent 1.62M USD +8.66%
Liabilities 47.3M USD -18%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) -1.24B USD -3.63%
Stockholders' Equity Attributable to Parent -6M USD -130%
Liabilities and Equity 41.3M USD -46.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.2M USD -8.47%
Net Cash Provided by (Used in) Financing Activities -2.41M USD -19.9%
Net Cash Provided by (Used in) Investing Activities 18.9M USD -27.9%
Common Stock, Shares Authorized 34.2M shares +50%
Common Stock, Shares, Issued 8.49M shares +44%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.28M USD -72.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 20.5M USD -24.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 210M USD +6%
Deferred Tax Assets, Gross 211M USD +5.99%
Operating Lease, Liability 2.95M USD +5.73%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -43.6M USD +7.19%
Lessee, Operating Lease, Liability, to be Paid 3.28M USD +6.78%
Property, Plant and Equipment, Gross 1.24M USD -48.7%
Operating Lease, Liability, Current 1.34M USD +2.38%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.29M USD -17.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.56M USD +3.04%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 324K USD +17.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 433K USD
Deferred Tax Assets, Operating Loss Carryforwards 104M USD +14.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 1.5M USD 0%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 863K USD +3.23%
Share-based Payment Arrangement, Expense 5.93M USD -1.22%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%